Cytokinetics Inc. Stock
Price
Target price
€52.00
€52.00
0.970%
0.5
0.970%
€83.92
19.07.24 / Tradegate
WKN: A1W1KK / Symbol: CYTK / Name: Cytokinetics / Stock / Biotechnology & Medical Research / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Cytokinetics Inc. Stock
Cytokinetics Inc. gained 0.970% compared to yesterday.
The stock is one of the favorites of our community with 34 Buy predictions and 1 Sell predictions.
As a result the target price of 83 € shows a very positive potential of 59.62% compared to the current price of 52.0 € for Cytokinetics Inc..
Criterium "Worthwhile Investment for the next years" is seen as the biggest plus for Cytokinetics Inc. stock. Negative votes have not been in the majority for any criteria for this stock
Pros and Cons of Cytokinetics Inc. in the next few years
Pros
?
W********* I********* f** t** n*** y****
?
M***** P*******
?
S********** s********
Cons
?
B****
?
C******** o* t** e**********
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Cytokinetics Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Cytokinetics Inc. | 0.970% | 1.961% | 7.438% | 75.676% | -32.026% | 108.000% | - |
| Ardelyx Inc. | 0.400% | -6.042% | -11.918% | 60.952% | -12.284% | 211.043% | - |
| Evolus Inc | 1.890% | 1.887% | 10.204% | 64.885% | 19.337% | 13.089% | - |
| Coherus Bioscien. | -1.880% | -0.956% | -2.907% | -61.062% | -50.559% | -86.459% | -90.599% |
Comments
Cytokinetics, Incorporated (NASDAQ: CYTK) had its price target lowered by analysts at JPMorgan Chase & Co. from $77.00 to $65.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for CYTK provided by MarketBeat
Cytokinetics, Incorporated (NASDAQ: CYTK) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $90.00 price target on the stock.
Show more
Ratings data for CYTK provided by MarketBeat
Cytokinetics, Incorporated (NASDAQ: CYTK) had its price target lowered by analysts at B. Riley from $122.00 to $92.00. They now have a "buy" rating on the stock.
Show more
Ratings data for CYTK provided by MarketBeat
